Search - tctmd.com

Displaying 241 - 260 of 790

Sort: Relevancy | Date

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

News Daily News

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

Todd Neale

August 12, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Daily News

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

L.A. McKeown

July 17, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Daily News

July 2020 News Roundup

L.A. McKeown

July 01, 2020

News Conference News EuroPCR 2020

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

L.A. McKeown

July 01, 2020

News Conference News TVT 2020

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Todd Neale

June 25, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Presenter: Hasan Jilaihawi

June 21, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Conference News ACC 2020

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

L.A. McKeown

April 07, 2020

News Conference News ACC 2020

New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals

Michael O'Riordan

April 06, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

Advertisement

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

July 2020 News Roundup

Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR

Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear

Device Explants After TAVR Rare but Risky

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

First Prospective Randomized Clinical Trial Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following Transcatheter Aortic Valve Implantation

Newer TAVR Devices Reassure in Failed Surgical Valves

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content